Masataka Ichikawa

3.4k total citations
146 papers, 2.5k citations indexed

About

Masataka Ichikawa is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Masataka Ichikawa has authored 146 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Organic Chemistry, 31 papers in Molecular Biology and 25 papers in Epidemiology. Recurrent topics in Masataka Ichikawa's work include Synthesis and biological activity (22 papers), Influenza Virus Research Studies (19 papers) and Synthesis and Characterization of Heterocyclic Compounds (19 papers). Masataka Ichikawa is often cited by papers focused on Synthesis and biological activity (22 papers), Influenza Virus Research Studies (19 papers) and Synthesis and Characterization of Heterocyclic Compounds (19 papers). Masataka Ichikawa collaborates with scholars based in Japan, United States and Uganda. Masataka Ichikawa's co-authors include T. HISANO, Keiko Mitamura, Masahiko Yamazaki, Chiharu Kawakami, Hitoshi Sasaki, Junzo Nakamura, Kenzo Yamamura, Norio Sugaya, Koyo Nishida and Mikiro Nakashima and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

Masataka Ichikawa

132 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Ichikawa Japan 25 811 638 460 250 240 146 2.5k
Toru Kino Japan 9 203 0.3× 1.2k 1.9× 417 0.9× 343 1.4× 74 0.3× 12 2.5k
Arlene S. Bridges United States 31 470 0.6× 1.2k 1.9× 413 0.9× 647 2.6× 58 0.2× 53 3.1k
Howard B. Cottam United States 35 675 0.8× 2.1k 3.3× 1.1k 2.4× 594 2.4× 53 0.2× 123 5.1k
J. Rhodes United Kingdom 33 694 0.9× 644 1.0× 134 0.3× 263 1.1× 63 0.3× 112 3.4k
Michael G. Natchus United States 29 585 0.7× 879 1.4× 744 1.6× 531 2.1× 44 0.2× 69 2.9k
Klaas Poelstra Netherlands 42 1.5k 1.9× 1.7k 2.7× 105 0.2× 621 2.5× 132 0.6× 155 5.2k
Theodor Weber Finland 25 178 0.2× 686 1.1× 557 1.2× 76 0.3× 87 0.4× 80 1.9k
Gerhard Hamilton Austria 35 682 0.8× 1.2k 1.9× 247 0.5× 1.5k 6.0× 66 0.3× 160 3.8k
Jingjing Zhu China 24 202 0.2× 793 1.2× 172 0.4× 320 1.3× 58 0.2× 116 2.0k

Countries citing papers authored by Masataka Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Masataka Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Ichikawa more than expected).

Fields of papers citing papers by Masataka Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Ichikawa. The network helps show where Masataka Ichikawa may publish in the future.

Co-authorship network of co-authors of Masataka Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Ichikawa. A scholar is included among the top collaborators of Masataka Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Ichikawa. Masataka Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takashita, Emi, Masataka Ichikawa, Seiichiro Fujisaki, et al.. (2024). Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients. International Journal of Infectious Diseases. 146. 107134–107134. 1 indexed citations
2.
Chu, Po–Sung, Nobuhiro Nakamoto, Yuya Hagihara, et al.. (2023). Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience. 26(3). 106220–106220. 7 indexed citations
3.
Namkoong, Ho, Masahiko Yamazaki, Noriaki Harada, et al.. (2018). Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma pneumoniae. Scientific Reports. 8(1). 1430–1430. 10 indexed citations
4.
Mitamura, Keiko, Hideaki Shimizu, Masahiko Yamazaki, et al.. (2013). Clinical evaluation of highly sensitive silver amplification immunochromatography systems for rapid diagnosis of influenza. Journal of Virological Methods. 194(1-2). 123–128. 34 indexed citations
5.
Mitamura, Keiko, Chiharu Kawakami, Hideaki Shimizu, et al.. (2012). Evaluation of a new immunochromatographic assay for rapid identification of influenza A, B, and A(H1N1)2009 viruses. Journal of Infection and Chemotherapy. 19(4). 633–638. 12 indexed citations
6.
Masago, Katsuhiro, Shiro Fujita, Yukimasa Hatachi, et al.. (2009). Effect of vascular endothelial growth factor polymorphisms on survival in advanced‐stage non‐small‐cell lung cancer. Cancer Science. 100(10). 1917–1922. 32 indexed citations
7.
8.
Sugaya, Norio, Keiko Mitamura, Masahiko Yamazaki, et al.. (2006). Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children. Clinical Infectious Diseases. 44(2). 197–202. 131 indexed citations
9.
10.
Yamamura, Kenzo, et al.. (1999). Characterization of Ocular Pharmacokinetics of Beta-Blockers Using a Diffusion Model After Instillation. Pharmaceutical Research. 16(10). 1596–1601. 19 indexed citations
11.
Yamada, Misato, Tomoki Nakashima, Hitoshi Sasaki, et al.. (1998). Change in Erythrocyte Shape Induced by Cyclosporine Administration.. Biological and Pharmaceutical Bulletin. 21(11). 1236–1239. 3 indexed citations
12.
Tokunaga, Yoshiharu, et al.. (1997). Antitumour Effects of 4-Pyridoxate Diammine Hydroxy Platinum, a Novel Cisplatin Derivative, Against Malignant Gliomas In-vitro and In-vivo: A Comparison with Cisplatin. Pharmacy and Pharmacology Communications. 3(7). 353–356. 2 indexed citations
13.
Sasaki, Hitoshi, Kenzo Yamamura, Takahiro Mukai, et al.. (1997). In Vivo Ocular Pharmacokinetic Model for Designing Dosage Schedules and Formulations of Ophthalmic Drugs in Human. Nagasaki University's Academic Output SITE (Nagasaki University). 42(3). 45–50. 8 indexed citations
14.
Nakashima, M, Hidetada Sasaki, Akihiro Ohira, et al.. (1997). In-vivo Ocular Microdialysis to Monitor Ocularly Applied Cyclosporin in the Anterior Chamber of Rabbits. Pharmacy and Pharmacology Communications. 3(4). 179–182. 2 indexed citations
15.
16.
Nakashima, Mikiro, et al.. (1996). In vivo Microdialysis to Determine the Relative Pharmacokinetics of Drugs.. Biological and Pharmaceutical Bulletin. 19(7). 988–994. 7 indexed citations
17.
Matsuyama, K, M Nakashima, Masataka Ichikawa, et al.. (1994). In Vivo Microdialysis for the Transdermal Absorption of Valproate in Rats.. Biological and Pharmaceutical Bulletin. 17(10). 1395–1398. 26 indexed citations
18.
Choshi, Tominari, Ching Y. Wang, Hisamitsu Nagase, et al.. (1992). Synthesis of Dibenzoylmethane Derivaives and Inhibition of Mutagenicity in Salmonella typhimurium.. Chemical and Pharmaceutical Bulletin. 40(4). 1047–1049. 30 indexed citations
19.
Nakashima, Mikiro, Yoshikazu Ishii, Kenji Matsuyama, et al.. (1989). Tissue Distribution of Cisplatin After Hepatic Arterial Injection of a Cisplatin–Lipiodol Suspension Containing Phosphatidylcholine to Rabbits Carrying VX-2 Hepatic Carcinoma. Pharmaceutical Research. 6(4). 342–345. 1 indexed citations
20.
Cohen, Samuel M., Masataka Ichikawa, & George T. Bryan. (1977). Carcinogenicity of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2) fed to female Sprague-Dawley rats.. PubMed. 68(4). 473–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Kino Breakdown of academic impact, for papers by Arlene S. Bridges Breakdown of academic impact, for papers by Howard B. Cottam Breakdown of academic impact, for papers by J. Rhodes Breakdown of academic impact, for papers by Michael G. Natchus Breakdown of academic impact, for papers by Klaas Poelstra Breakdown of academic impact, for papers by Theodor Weber Breakdown of academic impact, for papers by Gerhard Hamilton Breakdown of academic impact, for papers by Jingjing Zhu
Rankless by CCL
2026